C12N2770/28011 - CPC Classification

ssRNA viruses positive-sense; Details Hepeviridae

• C12N2770/28021 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 4
• C12N2770/28022 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 4
• C12N2770/28023 » Virus like particles [VLP] 0
• C12N2770/28031 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 0
• C12N2770/28032 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 0
• C12N2770/28033 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 5
• C12N2770/28034 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 8
• C12N2770/28041 » Use of virus, viral particle or viral elements as a vector 0
• C12N2770/28051 » Methods of production or purification of viral material 1
• C12N2770/28061 » Methods of inactivation or attenuation 1
• C12N2770/28071 » Demonstrated in vivo effect 0
• C12N2770/28088 » For redistribution 0
• C12N2770/28111 » Hepevirus, e.g. hepatitis E virus 1

Recent Application in this class: